Intermittent fasting is now the third most commonly practiced diet in the USA. Yet, despite more than 225 clinical trials—including nearly 40 in patients with diabetes or prediabetes—intermittent ...
The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
We interviewed a physician who provides guidance for patients with diabetes who wish to fast for religious or non-religious reasons. Fasting has been an integral part of religious practices for ...
GLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity ...
A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results